1. A172 C-EDGE CO-STAR: RISK OF REINFECTION FOLLOWING SUCCESSFUL THERAPY WITH ELBASVIR (EBR) AND GRAZOPREVIR (GZR) IN PERSONS WHO INJECT DRUGS (PWID) RECEIVING OPIOD AGONIST THERAPY (OAT). (1st March 2018) Authors: Conway, B; Dore, G J; Altice, F; Litwin, A; Grebely, J; Dalgard, O; Gane, E J; Shibolet, O; Luetkemeyer, A; Nahass, R; Peng, C; Gendrano, I; Huang, H; Chen, E; Nguyen, B; Wahl, J; Barr, E; Robertson, M; Platt, H Journal: Journal of the Canadian Association of Gastroenterology Issue: Volume 1(2018)Supplement 1 Page Start: 299 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
2. C‐EDGE CO‐STAR: RISK OF REINFECTION FOLLOWING SUCCESSFUL THERAPY WITH ELBASVIR (EBR) AND GRAZOPREVIR (GZR) IN PERSONS WHO INJECT DRUGS (PWID) RECEIVING OPIOID AGONIST THERAPY (OAT). Issue 4 (December 2016) Authors: Conway, B; Dore, G J; Altice, F; Litwin, A H; Grebely, J; Dalgard, O; Gane, E J; Shibolet, O; Luetkemeyer, A; Nahass, R; Peng, C‐Y1; Gendrano, I N; Huang, H‐C; Chen, E; Nguyen, B‐Y; Wahl, J; Barr, E; Robertson, M; Platt, H L Journal: Canadian Journal of Addiction Issue: Volume 7:Issue 4(2016) Page Start: Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗